These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19087839)

  • 1. [The most important methodological problems in studies of mortality and disease progression in patients with chronic obstructive pulmonary disease].
    Andrés Martínez J; Palomino Meneses R; Santiago Josefat B
    Arch Bronconeumol; 2008; 44 Suppl 2():11-20. PubMed ID: 19087839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New clinical parameters in chronic obstructive pulmonary disease].
    Izquierdo Alonso JL
    Arch Bronconeumol; 2008; 44 Suppl 2():4-10. PubMed ID: 19087838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Causes of death and risk factors for mortality in patients with severe chronic obstructive pulmonary disease].
    Moreno A; Montón C; Belmonte Y; Gallego M; Pomares X; Real J
    Arch Bronconeumol; 2009 Apr; 45(4):181-6. PubMed ID: 19328612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methodology and clinical impact of studies of mortality in chronic obstructive pulmonary disease].
    Soler-Cataluña JJ; Martínez García MA
    Arch Bronconeumol; 2008; 44 Suppl 2():21-8. PubMed ID: 19087840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA; Schumock GT; Bartle B; Pickard AS
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease.
    Briggs A; Spencer M; Wang H; Mannino D; Sin DD
    Arch Intern Med; 2008 Jan; 168(1):71-9. PubMed ID: 18195198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methodology and clinical impact of studies on disease progression].
    García Río F
    Arch Bronconeumol; 2008; 44 Suppl 2():29-38. PubMed ID: 19087841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease.
    Cooper CB; Dransfield M
    Am J Med; 2008 Jul; 121(7 Suppl):S33-45. PubMed ID: 18558106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.
    Decramer M; Gosselink R; Rutten-Van Mölken M; Buffels J; Van Schayck O; Gevenois PA; Pellegrino R; Derom E; De Backer W
    Thorax; 2005 Apr; 60(4):335-42. PubMed ID: 15790991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality.
    Pelkonen M
    Curr Opin Pulm Med; 2008 Mar; 14(2):105-9. PubMed ID: 18303418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
    Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
    J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in chronic obstructive pulmonary disease].
    Jiménez BA; Pumarega IC; Ausiró AM; Izquierdo Alonso JL
    Arch Bronconeumol; 2009; 45 Suppl 3():9-13. PubMed ID: 20116738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality in chronic obstructive pulmonary disease.
    Cote CG; Celli BR
    Clin Chest Med; 2007 Sep; 28(3):515-24, v. PubMed ID: 17720040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airflow obstruction and exercise.
    Cooper CB
    Respir Med; 2009 Mar; 103(3):325-34. PubMed ID: 19071004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease.
    van Eeden SF; Sin DD
    Respiration; 2008; 75(2):224-38. PubMed ID: 18042978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease.
    Grabicki M; Parysek H; Batura-Gabryel H; Brodnicka I
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():297-301. PubMed ID: 19218653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of leukotriene modifiers in the treatment of chronic obstructive pulmonary disease.
    Usery JB; Self TH; Muthiah MP; Finch CK
    Pharmacotherapy; 2008 Sep; 28(9):1183-7. PubMed ID: 18752388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.